Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 12.11.2026 MSEP.LN IE0009DRFET8  100,002.00 USD   2,843,103.09   28.430  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 12.11.2026 FJAN.LN IE000MDKBOB3  150,002.00 USD   4,448,318.01   29.655  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 12.11.2026 RDVY LN IE000K5F6EL4 1,300,002.00 USD  32,985,033.77   25.373  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 12.11.2026 FAPR.LN IE000WX2HZQ7  200,002.00 USD   5,250,089.22   26.250  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 12.11.2026 FTEG.LN IE0009F7UB30  125,002.00 EUR   2,771,152.50   22.169  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 12.11.2026 H2O LN IE000Q8F0M81  700,002.00 USD  14,269,127.30   20.384  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust RBA American Industrial Renaissance UCITS ETF 12.11.2026 AIRR LN IE000U6ABUJ7 9,475,002.00 USD 224,121,844.39   23.654  ...

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com's Third Quarter 2026 Results Highlight Operational Strength and Team Execution...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 12.11.2026 FJUL.LN IE000YJBT6I5  150,002.00 USD   4,389,848.51   29.265  ...

SAN DIEGO--(BUSINESS WIRE)--Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced new research published in Ophthalmology, the American Academy of Ophthalmology’s peer-reviewed journal. The publication reports that the polygenic risk score (PRS) underlying the company’s SightScore™ test can help identify people at substantially different levels of risk for developing glaucoma—and may also help predict disease progression and the likelihood of surgery. Glaucoma...